` SYNACT (SynAct Pharma AB) vs OMX Stockholm 30 Comparison - Alpha Spread

S
SYNACT
vs
O
OMX Stockholm 30

Over the past 12 months, SYNACT has significantly outperformed OMX Stockholm 30, delivering a return of +138% compared to the OMX Stockholm 30's 1% drop.

Stocks Performance
SYNACT vs OMX Stockholm 30

Loading
SYNACT
OMX Stockholm 30
Add Stock
www.alphaspread.com

Performance Gap
SYNACT vs OMX Stockholm 30

Loading
SYNACT
OMX Stockholm 30
Difference
www.alphaspread.com

Performance By Year
SYNACT vs OMX Stockholm 30

Loading
SYNACT
OMX Stockholm 30
Add Stock

Competitors Performance
SynAct Pharma AB vs Peers

OMX Stockholm 30
SYNACT
ABBV
AMGN
GILD
VRTX
Add Stock

SynAct Pharma AB
Glance View

Market Cap
1B SEK
Industry
Biotechnology

SynAct Pharma AB engages in the development of pharmaceutical drugs for the treatment of inflammatory diseases. The company is headquartered in Lund, Skane. The company went IPO on 2016-07-11. The firm is located in Lund, Sweden. The company develops medicines for acute impairment in inflammatory diseases. The firm's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

SYNACT Intrinsic Value
48.28 SEK
Undervaluation 56%
Intrinsic Value
Price
S
Back to Top